Diuretics And Beta-Blockers Are Best Drugs To Combat High Blood Pressure, Study Finds

March 19, 1998

St. Louis, March 19, 1998 -- Physicians use a small arsenal of newer drugs -- including calcium channel blockers, ACE inhibitors and alpha-blockers -- to lower high blood pressure. But the results of a study published in the March issue of Hypertension show that two older, less expensive types of drugs,

diuretics and beta-blockers, may lower blood pressure even better. This study, coordinated by a hypertension specialist at Washington University School of Medicine in St. Louis, analyzed data from 6,100 veterans treated at six Hypertension Screening and Treatment Program (HSTP) clinics of the U. S. Department of Veterans Affairs.

"The regimens of diuretic or diuretic plus beta-blocker gave the lowest average pressures and calcium channel blockers the highest," says H. Mitchell Perry Jr., M.D., professor emeritus of medicine at the School of Medicine and Physician Coordinator for Hypertension for the U.S. Department of Veterans Affairs. "There is a big difference in regimen efficacy, and it is statistically significant even after we correct for age, race and geographic region."

The study involved veterans receiving outpatient care at HSTP clinics in St. Louis, Mo., Indianapolis, Ind., Iowa City, Iowa, Memphis, Tenn., Jackson, Miss.and San Juan, Puerto Rico. These physician-supervised clinics, staffed by nurses and physician assistants intensively trained in hypertension, were established in 1974 by the Veterans Administration, as it was then called.

The physician-coordinators and staff members were allowed to choose which antihypertensive regimen to follow. They also could decide how aggressively to pursue the HSTP-recommended diastolic blood pressure goal.

The 46-month hypertension study, which ran from May 1989 to February 1993, did not follow a traditional randomized model. Instead, it relied on "real-world" data collected from clinicians who were primarily interested in treating patients and trying to find the medical regimen that would most effectively bring down blood pressure with a minimum of adverse effects.

"Unlike the more rigid, double-blind, placebo-controlled studies, this one simply says that we have a group of hypertensive patients and we're going to let the individuals who provide the care decide which drug to use and how enthusiastically to push it," Perry says.

The patients were a diverse group: their average age was 60.7 years, 53 percent lived in the five southeastern "Stroke Belt" states, 36 percent were black and 14 percent Hispanic, 23 percent smoked and 10 percent had diabetes mellitus. Of the 6,025 men and 75 women, 46 percent had damage to retina, heart, peripheral blood vessels, kidney or central nervous system -- all organs that are affected by high blood pressure.

Each time a patient visited an HSTP clinic, the staff recorded items of clinical importance, especially blood pressure and medication data. Some patients were taking no antihypertensive drug, while others were taking one or more drugs from the list of common agents: diuretics, beta-blockers, ACE inhibitors, calcium channel blockers or sympatholytic agents that were not beta-blockers. Some 54 percent took a diuretic, most commonly hydrochlorothiazide, and 33 percent took a calcium channel blocker, most often verapamil.

Researchers from the VA Coordinating Center in Perry Point, Md., divided these regimens into 12 categories and analyzed them. The results were decisive: the regimens of diuretic or diuretic plus beta-blocker produced the lowest average pressures (140.1/81.9 mm. Hg) and calcium antagonists the highest (149.0/86.5 mm. Hg).

All of the medications brought some patients down to the HSTP goal. But the pattern of lower treated pressure with the older agents and higher treated pressure with the newer ones was reflected in the percentages of patients whose blood pressure was controlled.

A second part of this study will retrospectively examine the morbidity and mortality associated with the various antihypertensive agents. A much larger traditional blinded and randomized trial, the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), is also scheduled for completion in 2001. This study, funded by the National Heart, Lung, and Blood Institute and the Department of Veterans Affairs, will prospectively examine morbidity and mortality associated with three of the "new" antihypertensive agents, comparing them to diuretics which are considered the gold standard.

"This ALLHAT study should answer the bottomline question: Are any of the currently used antihypertensive agents more effective than others in preventing death or heart attacks or strokes? We think these catastrophic events are closely associated with decrease in blood pressure, but we want to be sure," says Perry.
-end-
Perry HM, Bingham S, Horney A, Rutan G, Sambhi M, Carmody S, Collins J. Antihypertensive efficacy of treatment regimens used in Veterans Administration hypertension clinics. Hypertension, 31, March 1998.



Washington University School of Medicine

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.